| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd6a917a8523bd9c3e6060769d7ffd02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d3a63854c7a1afe23086eebce835f46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d92c46f60af8af24e262b67381d7eb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
1995-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f09e8ff7189da1e15d3d44f194437b80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460820882ee696cda938005f4bd4ff22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_100aeb23cb4de09020ba882d86b04252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66497dda777015d8fe023ae07290f812 |
| publicationDate |
1998-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5830676-A |
| titleOfInvention |
Diagnosis with MCC |
| abstract |
A new human gene termed MCC is disclosed. Antibody based methods and kits are provided for assessing mutations of the MCC gene in human tissues and body samples. Gross rearrangement and point mutations in MCC are observed in human tumor cells. MCC is expressed in most normal tissues. These results suggest that MCC is a tumor suppressor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10155980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11427866-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11643683-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11203782-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10767222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1711813-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10724088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1711813-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578359-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752942-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11286519-B2 |
| priorityDate |
1991-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |